Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Public ClinicalTrials.gov record NCT03104517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CELLEBRATE: A Double-Blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Persistent or Recurrent Stress Urinary Incontinence Following Surgical Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction of stress incontinence episode frequency in adult female patients with post-surgical persistent or recurrent stress urinary incontinence (SUI). Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.
Study identification
- NCT ID
- NCT03104517
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2019 (Actual)
- Primary completion
- Jun 11, 2026 (Actual)
- Completion
- Nov 2026 (Estimated)
- Last update posted
- Oct 21, 2026
2019 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Del Sol Research Management, LLC | Tucson | Arizona | 85715 | — |
| San Diego Clinical Trials | La Mesa | California | 91942 | — |
| UCLA Women's Health Clinical Research Unit/Department of OBGYN | Los Angeles | California | 90095 | — |
| Stanford Hospital and Clinics | Stanford | California | 94305 | — |
| American Association of Female Pelvic Medicines Research Institute | Westlake Village | California | 91361 | — |
| MedStar Georgetown Hospital Department of Urology | Washington D.C. | District of Columbia | 20007 | — |
| University of Kansas Health System | Kansas City | Kansas | 66160 | — |
| Bennett Institute of Urogynecology and Incontinence | Grand Rapids | Michigan | 49456 | — |
| University of New Mexico Women's Care Clinic | Albuquerque | New Mexico | 87131 | — |
| AccuMed Research Associates | Garden City | New York | 11530 | — |
| Northwell Health/The Arthur Smith Institute for Urology | Lake Success | New York | 11042 | — |
| Columbia University Irving Medical Center | New York | New York | 10032 | — |
| Atrium Health | Charlotte | North Carolina | 20207 | — |
| Cleveland Clinic/Glickman Institute-Q10 | Cleveland | Ohio | 44195 | — |
| Magee Women's Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Sanford Female Pelvic Medicine and Reconstructive Surgery Clinic | Sioux Falls | South Dakota | 57105 | — |
| Vanderbilt University Medical Center, Dept. of Urologic Surgery | Nashville | Tennessee | 37232 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Cedar Health Research | Irving | Texas | 75062 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03104517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 21, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03104517 live on ClinicalTrials.gov.